1. Home
  2. BNKK vs BFRI Comparison

BNKK vs BFRI Comparison

Compare BNKK & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNKK

Bonk Inc.

HOLD

Current Price

$1.28

Market Cap

13.0M

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$1.06

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNKK
BFRI
Founded
2018
1997
Country
United States
United States
Employees
10
94
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0M
13.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNKK
BFRI
Price
$1.28
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
143.4K
381.2K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.36
Revenue Next Year
N/A
$16.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.57
52 Week High
$7.19
$1.21

Technical Indicators

Market Signals
Indicator
BNKK
BFRI
Relative Strength Index (RSI) 36.07 52.43
Support Level $0.12 $0.77
Resistance Level $1.66 $1.14
Average True Range (ATR) 0.09 0.09
MACD 0.01 -0.00
Stochastic Oscillator 24.26 48.73

Price Performance

Historical Comparison
BNKK
BFRI

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: